Eli Lilly’s Weight Loss Pill Will Likely Be The Market-leading Product, Says BofA’s Tim Anderson

Tim Anderson, BofA Securities senior pharma analyst, joins ‘Squawk Box’ to discuss news of Eli Lilly’s weight loss pill orforglipron clearing its latest trial, what it means for the drug going forward, and more.